價值投機的巴韭特:prometheus(rxdx)112.4:嬰幼兒保健
嬰幼兒保健描述::價值投機的巴韭特:
Prometheus(RXDX)112.48 賣出,記錄一下
Prometheus(RXDX):
Prometheus(RXDX) 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-22-300151 Act: 33 Size: 415 KB 網頁鏈接
Prometheus(RXDX):
Prometheus(RXDX) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-061088 Size: 7 KB 網頁鏈接
Prometheus(RXDX):
Prometheus(RXDX) 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-22-301821 Act: 33 Size: 441 KB 網頁鏈接
Prometheus(RXDX):
Prometheus(RXDX) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-062264 Size: 5 KB 網頁鏈接
Prometheus(RXDX):
Prometheus(RXDX) 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-22-301839 Act: 34 Size: 467 KB 網頁鏈接
Prometheus(RXDX):
Prometheus(RXDX) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-061089 Size: 7 KB 網頁鏈接
產業鏈觀察:
#藥聞簡訊# Prometheus(RXDX)宣布PRA023在ARTEMIS-UC 2期和APOLLO-CD 2a期研究中均取得陽性結果,為這兩項同類首創產品提供了有利的途徑.
Prometheus(RXDX):
Prometheus(RXDX) 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-22-299773 Act: 34 Size: 13 MB 網頁鏈接
Prometheus(RXDX):
Prometheus(RXDX) 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-061090 Size: 7 KB 網頁鏈接
Prometheus(RXDX):
華盛資訊12月7日消息,美股盤初,生物技術公司Prometheus Biosciences逆市大漲,截至發稿現漲178.51%,報100.43美元,成交額5.098億美元。此前公司報告了其主要候選產品PRA023在炎癥性腸病方面的兩項研究的積極結果。 數據庫軟件公司MongoDB... 網頁鏈接
Prometheus(RXDX):
Prometheus(RXDX) 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-22-037201 Act: 34 Size: 377 KB 網頁鏈接